ELI LILLY AND COMPANY News
4 articles from 1 publishers (CNBC), 2026-09-21 to 2026-09-27, newest first. SEC Form 8-K current reports are under SEC Filings › Other Filings.
| Date | Publisher | Type | Headline |
|---|---|---|---|
| 2026-09-27 | CNBC | Top News | Here are the 4 big things we're watching in the stock market in the week ahead Both sides of the Fed's dual mandate are in focus. Plus, Micron reports and Eli Lilly delivers updates on its obesity pipeline. |
| 2026-09-25 | CNBC | Business | Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the top of the obesity drug market. |
| 2026-09-21 | CNBC | Business | Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space. |
| 2026-09-21 | CNBC | Business | Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July. |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |